Study Finds Increased Hospitalizations and Reduced Hospice Use in Patients Near End of Life Receiving Anti-Cancer Treatments
Research shows that cancer patients receiving aggressive treatments near death are hospitalized more often and less likely to access hospice care, impacting quality of life.
Recent research conducted by the University of Texas MD Anderson Cancer Center highlights a concerning trend in end-of-life cancer care. The study reveals that patients who undergo systemic anti-cancer therapies—such as chemotherapy, immunotherapy, or targeted treatments—closer to death are significantly more prone to hospitalization, intensive care admissions, and emergency department visits within the last 30 days of life. Conversely, these patients are less likely to access hospice services, which are essential for providing comfort and support in terminal stages.
The analysis, which utilized data from over 315,000 older adults with various cancers from the SEER Medicare database (2015-2020), showed that receiving cancer treatment near the end of life increases the likelihood of emergency room visits by threefold, hospital stays by 2.6 times, and ICU admissions by 1.8 times. Additionally, there is a higher chance of dying in the hospital and a lower probability of utilizing hospice care.
This pattern was consistent across different types of systemic therapies, emphasizing a broad issue in current end-of-life care practices. Dr. Kerin Adelson, chief quality and value officer at MD Anderson, commented that the overuse of aggressive cancer treatments late in life can cause significant harm. It often results in a more medicalized death—marked by unnecessary interventions, hospital stays, and out-of-home death locations—detracting from quality of life and emotional well-being for patients and their families.
The findings suggest the need for policy reforms and enhanced communication strategies to align treatment decisions more closely with patients’ wishes and quality of life goals. MD Anderson has made strides in reducing chemotherapy overutilization by promoting conversations about prognosis and end-of-life preferences, which is vital for providing compassionate, patient-centered care. Overall, this research underscores the importance of considering less aggressive, more supportive options in end-of-life cancer care.
Source: https://medicalxpress.com/news/2025-09-patients-anti-cancer-treatment-life.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
National Audit Highlights Strengths and Opportunities in Medication Oversight in Australian Aged Care
A new national audit by Monash University reveals the strengths and areas for improvement in medication oversight within Australian residential aged care, emphasizing the pivotal role of Medication Advisory Committees in promoting safety and quality.
One-Third of Licensed GPs in England Not Practicing in NHS General Practice
A new study reveals that one-third of licensed GPs in England are not working within NHS primary care, highlighting workforce challenges and increasing patient workloads.
Advancements in Bird Flu Vaccine and Insights from Organoid Research Reveal Impact of H5N1 on Airways
Researchers develop a promising bird flu vaccine and use organoid models to understand how H5N1 damages airway tissues, opening new avenues for treatment and prevention.
Establishing a Global Standard for Measuring Outcomes in Dengue Treatment Trials
A new global standard for measuring outcomes in dengue treatment trials has been published, aiming to unify clinical research methods and accelerate the development of effective therapies for the rapidly spreading disease.